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Abstract Article Info 
Introduction: Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer, mostly associated with 
EBV infection. Nuclear factor kappa B (NF-κB) is transcription factors that act as a tumor promoter, especially 
in inflammation-associated cancer. It also attracts angiogenesis. Microvessel Density (MVD) is widely used as 
an index for tumor angiogenesis. There have been no studies found about the correlation of NF-κB and MVD 
expression in NPC.  
Objective: The aim of this study is to investigate the correlation of NF-κB and MVD expression that may affect 
targeted therapies in NPC patients 
Methods: A total of 30 paraffin blocks of NPC patients biopsies were assessed immunohistochemically for NF-
κB expression and MVD. Data were analyzed using the Spearman's nonparametric test to assess the correlation 
between NF-κB expression and MVD.  
Results: Positive NF-κB expression was found in 22 (73.33%) patients and negative in 8 (26.67%) patients. 
High MVD expression in 17 (56.67%) patients and low MVD expression in 13 (43.33%) patients. There was no 
significant correlation found between NF-κB and MVD.  
Conclusion: This study has not confirmed any correlation between NF-κB and MVD. Further research needs to 
be done to get a better assessment on nuclear proliferation rates and tumor-related angiogenesis in NPC. 
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1. INTRODUCTION 
Nasopharyngeal carcinoma (NPC) is an aggressive head and neck 
cancer frequently found especially in endemic regions such as Southeast 
Asia. Etiological factors of NPC consist of genetic, environmental, and viral 
factors. Epstein-Barr virus (EBV) infection is considered to play an 
important role as around 90% of the adult population throughout the world 
is EBV-positive [1, 2]. 
Almost 98% of NPC are associated with EBV infection. Non-
keratinizing is more consistently associated with EBV compared to 
keratinizing NPC. The EBV encoded latent membrane proteins (LMP1) 
activate multiple signaling pathways including NF-κB, and stimulate the 
growth of NPC by up-regulating growth factor receptors and suppressing 
cell cycle regulators [2].  
Nuclear factor kappa B (NF-κB) is transcription factors in the cell 
cytoplasm and when activated it will translocate into the nucleus. Its 
activation is induced by various types of agents such as stress, cigarette 
smoke, viruses, bacteria, inflammatory stimuli, cytokines, free radicals, 
carcinogens, tumor promoters and endotoxins.  NF-κB and the signaling 
pathways that activate them coordinate the innate and adaptive immune 
centers.  NF-κB works by inhibiting apoptosis (programmed cell death), 
increases cell proliferation and the inflammatory and immune response. 
Recently, misregulated NF-κB activity has been known to have an important 
role in cancer development and progression [3, 4].  
NF-κB has five different family members, they are:  NF-κB1 
(p50/p105), NF-κB2 (p52/p100), RelA (p65), RelB and c-Rel. Before 
translocated into the nucleus, NF-κB1 and NF-κB2 are cleaved to the active 
p50 and p52 subunits, respectively. Two different NF-κB activational 
pathways have been identified, a classical (canonical) pathway and an 
alternative (non-canonical) pathway [3-6].  
NF-κB canonical pathway is mediated by an NF-κB essential modulator 
(NEMO)-dependent inhibitory kappa B kinases (IKK), while the non-
canonical pathway does not require NEMO [3, 4]. Pathogens and 
inflammatory signals activating NEMO/IKK will activate the canonical 
pathway. This activation will result in degradation of IκBα/IκBβ/IκBε and 
nuclear translocation of RelA: p50, RelA:RelA and cRel:p50 dimer. Genes 
responsible for inflammation and survival will then be activated. Non-
canonical pathway, however, will be activated through developmental 
signals activating NIK/IKK1. IkBδ will be degradated and p100 will be 
processed and nuclear translocation of Rel A:p50, RelB: p50 and RelB:p52 
dimers will take place, eventually it will activates the genes responsible for 
organ development [4]. By knowing the significance and specific pathways 
involved in activation, the opportunity to find targeted therapies to prevent 
the development of NPCs at an early stage will be widely open.  
NF-κB can play 2 opposing roles in tumorigenesis. First, it acts as an 
inducer for the immune cells to express inflammatory cytokines, which 
then enhance tumor cell survival and angiogenesis. Second, it also 
promotes apoptosis via death receptors and Fas/CD95 and thereby delays 
tumor progression [7]. 
Neoangiogenesis plays an important role in tumor growth and 
metastasis formation. It provides adequate oxygenation and nourishment for 
the tumor. This process of neovascularization depends on the ability to 
release specific factors that stimulate and inhibit new blood vessel formation 
[8]. Angiogenic vessels can be visualized with immunohistochemical 
staining, either using monoclonal antibody or endothelial cell antigens [9]. 
Assessing microvessel density (MVD) is a way to evaluate the role of 
neoangiogenesis in the tumor progression. The aim of this study is to 
investigate the correlation of NF-κB expression and MVD  that may affect 
targeted therapies in NPC patients.  
2. MATERIAL AND METHODS 
2.1 Case selection 
A total of 30 paraffin blocks were retrieved from biopsies of NPC 
patients who have never received treatment such as radiotherapy, 
chemotherapy or a combination of both.  
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2.2 Immunohistochemical staining  
The paraffin blocks were assessed for immunoreactivity of NF-κB 
antibody. The level of NF-κB antibody intranuclear expression in tumor cells 
was evaluated by adding a score of intensity of staining and the score of area 
of staining (score of immunoreactivity). The intensity of staining identified 
under 40x magnification and categorized into four grades: 0 (background), 1+ 
(weak), 2+ (moderate), and 3+ (strong). The area of staining was evaluated as 
follows: 0, no staining of cells in any microscopic fields; score 1 <25%, 2=25-
50%, 3=>50% stained positive. The expression of NF-κB was further assessed 
using two scales: low expression (score of immunoreactivity=0-3) and high 
expression (score of immunoreactivity=4-6).   
The material from the same tissue is also examined immunohistochemically 
by using anti-Human Monoclonal Mouse CD31 Endothelial cell for calculating 
the micro blood vessel density. With a 40x magnification an area with the highest 
blood vessel is identified and named the ‘hot spot’ area. The vascular endothelial 
cell groups with or without lumen were calculated at 200x magnification. The 
measurement results are expressed in the total number of micro blood vessels 
(MV) per field of view. Total number of micro blood vessels >45 is considered 
high and <45 is considered low MVD. These evaluations were carried out by 3 
pathologists without knowing the clinical data of the patients. The study was 
approved by the Health Research Ethical Committee of Universitas Sumatera 
Utara, Medan, Indonesia (No. 41/ KOMET/ FK USU/ 2015). 
Data were analyzed using the Spearman's non parametric test and processed 
using SPSS 23 program to assess the correlation between NF-κB levels and MVD. 
A     B 
 
C                  D 
Picture 1. A. NF-κB expression in placental control tissue with 40x 
magnification. B. NF-κB expression score +3 in NPC tissue with 40x 
magnification. C. NF-κB expression score +2 in NPC tissue with 40x 
magnification. D. NF-κB expression score +1 in NPC tissue with 40x 
magnification 
 
A     B 
Picture 2. Expression of high MVD and low MVD (b) with 200x 
magnification 
3. RESULT  
A total of 30 NPC patients were analyzed. The clinicopathological 
characteristics of these patients were presented in table 1.  
Table 1. Patients’ characteristics 
Characteristics n % 
Age (year) 
   ≤20 
   21-40 
   41-60 
   >60 
 
1 
6 
18 
5 
 
3.33 
20.0 
60.0 
16.67 
Gender 
   Male  
   Female  
 
21 
9 
 
70.00 
30.00 
Histopathology  
   Keratinizing squamous cell carcinoma 
   Non-keratinizing carcinoma 
   Undifferentiated carcinoma 
 
1 
16 
13 
 
3.33 
53.34 
43.33 
Tumor grade 
   T1 
   T2 
   T3 
   T4 
 
7 
5 
7 
11 
 
23.33 
16.67 
23.33 
36.67 
Grade of metastatic lymph node  
   N0 
   N1 
   N2 
   N3 
 
1 
8 
8 
13 
 
3.33 
26.67 
26.67 
43.33 
Stage  
   I 
   II 
   III 
   IV 
 
0 
3 
6 
21 
 
0.00 
10.00 
20.00 
70.00 
Most of the patients are in the age range of 41-60 years old. Male (70%) 
are more common than female. Most common histopathology type was non-
keratinizing squamous cell carcinoma (53.34%).  Most of the patients were 
in advance stage, stage III and IV, 20% and 70% respectively.   
Table 2. Frequency distribution of NF-κB expression  
NF-κB Expression n % 
High 22 73.33 
Low 8 26.67 
Total 30 100 
 
Based on immunohistochemical examination, positive NF-κB expression 
was found in 22 (73.33%) patients and negative in 8 (26.67%) patients. 
Table 3. Frequency distribution of MVD expression 
MVD Expression n % 
High 17 56.67 
Low 13 43.33 
Total 30 100 
 
Immunohistochemical examination in nasopharyngeal carcinoma tissue 
showed high MVD expression in 17 (56.67%) patients and low MVD 
expression in 13 (43.33%) patients. 
Table 4. Correlation of NF-κB with MVD expression 
   MVD 
Spearman’s rho NF-κB Correlation coefficient 
Sig. (2 tailed) 
N 
-.223 
.236 
30 
r= -.223, p>0.05 
Table 4 showed no significant correlation was found between NF-κB 
and MVD). 
4. DISCUSSION 
NPC is a head and neck cancer that is frequently found in Indonesia. It 
is rated as the fourth most common tumor after cervical, breast, and skin 
cancer [10]. In Indonesia, the overall prevalence of NPC is estimated at 
6.2/100,000 or about 12,000 new cases per year [10]. And around 75-90% 
of NPC patients were classified as locally advanced stages (stage III and IV) 
at the point of diagnosis [11, 12].  
According to Adham et al (2012) the undifferentiated type (WHO NPC 
type III) is the most frequent histopathologic type, and most closely 
International Journal of Nasopharyngeal Carcinoma (IJNPC) Vol. 02, No. 02, 2020 | 40-43 
 
 
 
  
42 
 
associated with EBV infection. This EBV infection is affecting over 95% of 
the global adult population [10, 11].  
In this study, most of the patients were diagnosed with non-keratinizing 
carcinoma (53.34%) and stage III and stage IV, being the most frequent, 
were 20 and 70%, respectively.  Li and Yong (2014) cited that non-
keratinizing carcinoma comprises over 95% of NPC in high incidence areas 
and approximately 75-87% in low incidence areas. These types of tumors 
are generally more radiosensitive compare to squamous cell carcinoma and 
have stronger relationships with EBV also [13].   
In this study we found 22 (73.33%) patients with positive NF-κB 
expression (table 2). This corresponds to the study of Rofi’i1et al (2013) 
in which they reported higher expression of NF-κB in NPC tissue 
compared to normal nasopharyngeal tissue [14]. Earlier studies have also 
shown distinct types of NF-κB complexes in EBV-positives NPC cells 
[15, 16]. NPC is the best known inflammation-rich background cancer 
that is related to the virus-associated human cancers, EBV [17]. These 
findings support a crucial role of activated NF-κB signals especially in 
EBV-positive NPC. NF-κB has been reported to have the ability to 
regulate several proteins that promote tumors growth, invasion, and 
metastasis, such as urokinase-type plasminogen activator and matrix 
metallopeptidase 9 (MMP-9). NF-κB also has functioned as a tumor 
promoter in inflammation-associated cancer. NF-κB activation and 
interactions with the microenvironment most likely play an important role 
not only in carcinogenesis but also in tumor invasion and metastasis [18].  
Angiogenesis, or the formation of new blood vessels, is essential in 
tumor cell survival, which leads to tumor metastasis. Newly formed blood 
vessels provide increased oxygen and nutrients that are essential for the 
tumor to grow [19]. MVD is widely used as an index for tumor angiogenesis. 
Elevated MVD has been reported leads to a rapidly growing tumor with 
potential invasion, metastasis, and recurrence [17, 20].  
We found high MVD expression in 17 (56.67%) patients and low MVD 
expression in 13 (43.33%) patients in the present study. Zhuo et al (2015) 
reported the status of MVD in NPC patients and they found higher MVD 
expressions in NPC patients with distant metastases (44.67±7.90) compared 
to those without distant metastases (42.90±8.38) [21]. In addition, 
Szafarowski et al (2018) showed that MVD expressions were found to be 
significantly elevated in the head and neck squamous cell carcinomas 
compared to the non-malignant control tissues (p=0.001) and to dysplastic 
tissues [22]. These studies revealed that immunohistochemical staining on 
microvessels density may provide valuable information about tumor 
progression and distant spread of NPC.  
Correlation between NF-κB and MVD in NPC has not yet been 
established in previous studies. In the present study the analysis did not 
confirm any significant correlation between NF-κB and MVD in NPC. On 
the contrary, a study on adenoid cystic carcinoma of the salivary gland 
revealed a significant correlation between NF-κB and MVD [19].  
There have been many studies measuring expression of NF-κB or MVD 
in cancer tissues, but with many variability in results and significance. 
Several different factors may affect these results. There were variations in 
study designs. Some studies counted ‘hot spots’ and some other used 
different cut off values to assess the expression of NF-κB [14, 19, 23, 24]. 
In this study we evaluated both the area percentage and immunostaining 
intensity score to be added up and obtain a total score of immunoreactivity 
as has been done in a recent research [25]. Similar concerns apply in the 
terms of methods for measuring microvascular density. Besides manual, 
MVD count can also be done by using computerized-image analysis systems 
[23]. But most studies have performed manual method as it is more suitable 
and available in almost all medical facility. For this reason, we chose to use 
manual method for counting MVD. Other concern may be the cut-off values 
selected in MVD analysis. There is no definite standard to determine MVD 
values. Some studies have used mean MVD value as cut-off points [21, 26], 
other derived arbitrary values from statistical analyses [22]. In this study 
MVD values were obtained between 0-122 microvessel per field of view 
with an average of 47+30,906. Based on previous study, we referred MVD 
value as high if total microvessel >45 per field of view [27].  
We are aware that our study didn’t examined a homogenous group of 
NPC cases and included all subtypes of NPC and tumor stages. Therefore, 
these differences may be the reason why this particular study did not find 
any correlation between NF-kB and MVD. Further data collection is 
required to determine how exactly NF-kB and MVD is correlated.  
5. CONCLUSION 
This study has not confirmed any correlation between NF-κB and 
MVD. Nevertheless, positive NF-κB expression and high MVD were found 
many among these patients. In the future, further research needs to be done 
to get a better assessment on  nuclear proliferation rates and tumor-related 
angiogenesis in NPC. 
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